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Abstract This study identifies the risk factors for hepatitis B virus (HBV) and hepatitis C virus 
(HCV) and measures the prevalence of hepatitis B surface antigen (HBsAg) and antibody to hepatitis C 
(anti-HCV) in the general population of Jakarta. A population-based sample of 985 people aged 15 and 
above was surveyed. Risk factors were identified through questionnaires and home visits. Serum was 
analysed for HBsAg, antibody to hepatitis B surface antigen (anti-HBs), anti-HCV, aspartate 
aminotransferase (AST) and alanine aminotransferase (fin. The seroprevalence was: 4.0% (39/985) 
for HBsAg, 17.2% (170/985) for anti-HBs, and 3.9% (38/985) for anti-HCV. The risk factors for 
hepatitis B and hepatitis C infection had little in common. Low socioeconomic status was a strong risk 
factor for HBsAg (adjusted odds ratio (OR) 18.09; 95% confidence interval (CI) 2.35-139.50). In 
addition, the Chinese group has 2.97 higher risk of having HBV infection compared with the Malayan 
ethnic group (adjusted OR 2.97; 95% CI 1.22-7.83). There was moderate positive trend between 
family size and risk of HBsAg positivity (P = 0.130). Age over 50 (adjusted OR 14.72; 95% CI 
4.35-49.89) and history of transfusion were significant risk factors for hepatitis C (adjusted OR 3.03; 
95% CI 1.25-7.33). Hepatitis B and hepatitis C infections have different risk factors in Jakarta, a high 
risk in population for both diseases. Hepatitis B transmission is associated with low socioeconomic 
status, Chinese ethnic group and large family size, while hepatitis C is associated with an older age and 
a history of transfusions. 
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INTRODUCTION 
The development of a sensitive serological test for 
hepatitis C virus infection (HCV) has shown that this 
virus is the primary aetiological agent of parenterally 
transmitted non-A, non-B hepatitis (NANB hepatitis) 
and an important cause of acute and chronic hepatitis 
worldwide. Risk factors and routes of transmission for 
this disease are known to include transfusions with 
blood and its products. The role of intimate contact 
remains to be elucidated.' Most previous studies of the 
epidemiology of antibody to hepatitis C (anti-HCV) 
and hepatitis B virus (HBV) markers have focused on 
special groups such as blood donors, haemophilia 
patients and hospital-based patients, who are at risk as a 
result of percutaneous exposures to blood products. 
Although most studies of hepatitis C have focused on 
transfusion recipients, the majority of HCV infections 
are currently outside the transfusion setting.',2 
Previous studies of high-risk groups in South-East Asia 
suggest that the risk factors for hepatitis C and hepatitis 
B in this part of the world may differ from those in 
Europe and the United  states."^^ Epidemiological 
studies among blood donor populations and hospital- 
based patients do not really represent the general 
population.'o This study presents some risk factors for 
HCV and HBV infection in the general population and 
defines the roles of socioeconomic status, ethnic group, 
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and family size as risk factors for HBV infection; and age 
and transfusion as risk factors for HCV infection. 
METHODS 
This study was conducted from January to June 1994 in 
an urban subdistrict of Central Jakarta, Indonesia and 
consisted of 34 666 people in 7017 households. We 
randomly selected 340 households and all the household 
members aged 15 and above were asked to participate. 
A total of 1150 subjects from these households were 
eligible to participate in the study. Specially trained 
nurse-midwives visited the houses of eligible subjects to 
evaluate their socioeconomic condition and to invite the 
subjects to visit a local, participating hospital for this 
study. The nurse-midwives then conducted structured 
interviews with the subjects at the participating hospital 
regarding demographic characteristics and risk factors 
for HBV and HCV infection. Blood samples for the 
examination of hepatitis B surface antigen (HBsAg), 
antibody to hepatitis B surface antigen (anti-HBs), anti- 
HCV, aspartate aminotransferase (AST), and alanine 
aminotransferase (ALT) were taken. 
Self-reported factors under study included gender, 
age (15-29, 30-49, 50 and above), education level 
(high, study at college/university or a higher level; 
middle, study at junior or senior high school; low, 
illiterate, capable of reading only, or study not beyond 
primary school), current alcohol use (yedno), current 
cigarette smoking (yedno), participation in regular sport 
(yedno), history of surgical operations (yedno), history 
of transfusion (yedno), history of jaundice (yesho), 
family history of jaundice (yes/no), and history of 
hepatitis B vaccination (yesho) . Socioeconomic status 
(high/middle/low) was determined by the evaluation of 
the nurse-midwife, based on the housing condition, 
ownership of transportation, ownership of housing 
appliances, and the availability of electricity. 
Laboratory factors under study included HBsAg, anti- 
HBs, anti-HCV, AST and ALT levels. Aspartate amino- 
transferase and ALT laboratory tests were carried out 
with an automated photometric analyser (model 737, 
Hitach-Boehringer Mannheim, Hitachi, Tokyo, Japan). 
Normal AST level was considered to be less than 
38 IU/dL for males and less than 32 IU/dL for females; 
normal ALT level was considered to be less than 42 
IU/dL for males and less than 32 IU/& for females. 
Tests for HBsAg and anti-HBs were done using 
reverse passive haemagglutination (RPHA) and passive 
haemagglutination (PHA) consecutively. Anti-HCV 
testing was done using a dipstick test developed at 
Laboratoria Hepatika Mataram, Lombok, Indonesia. 
This test uses HCV core-derived synthetic peptides CP9 
(amino acid [aa] 39-74) and CP14 (aa 5-40) as solid 
antigens which are recognized by anti-core antibodies. It 
has been shown to have equal sensitivity to commonly 
used second-generation enzyme-linked immunosorbent 
assay (anti-HCV Elisa 11; Ortho Diagnostics Systems, 
Tokyo, Japan).’ All sera were collected and kept at 
-20°C prior to the assessment. 
Logistic regression analysis* was used to control the 
confounding effects of other characteristics and exposures 
on the relation to HBsAg and anti-HCV. A variable was 
considered to be a confounder if its inclusion in a model 
changed the odds ratio by more than 10%. Charac- 
teristics that fulfilled this definition as confounders are 
included in the models presented. Odds ratios were 
estimated by the method of maximum likelihood, and 
their 95% confidence intervals (CI) were based on the 
standard error of coefficient estimates. 
The Ethics Committee of the Department of Internal 
Medicine, School of Medicine, University of Indonesia 
approved this study. Informed consent was obtained 
from participants in this study. 
RESULTS 
Of the 1150 invited subjects, 1020 respondents (89%) 
participated in this study. Of these we excluded 35/1020 
subjects (3.4%) due to incomplete and/or conflicting 
data, leaving a total of 985 subjects. 
The excluded 35 subjects consisted of 17 male and 
18 female. By socioeconomic status the excluded 
subjects were as follows: seven belonged to high-level 
socioeconomic status, 12 middle-level socioeconomic 
status and 16 low-level socioeconomic status; by age 
group there were 14 persons aged 15-29 years old, 12 
persons aged 30-49 years old, and nine persons aged 
50 years and over. The 130 non-respondents consisted 
of 56 males and 74 females; 26 of high-level socio- 
economic status, 46 of middle-level socioeconomic 
status, and 58 of low-level socioeconomic status. By age 
group there were 55 persons aged 15-29 years old, 43 
persons aged 30-49 years old and 32 persons aged 50 
years and over. In terms of gender, socioeconomic 
status, and age group, the excluded subjects and non- 
respondents were not significantly different compared 
with the 985 subjects which were included in this 
analysis. 
We assumed there were not acute hepatitis cases 
found in our study because the maximum range of AST 
and ALT among our subjects was less than 2.5 times 
the normal limits. The range of AST in our study was 
11-92 U L ,  while ALT ranged from 9 to 87 UL. 
Hepatitis B 
Thirty-nine subjects tested positive for HBsAg and 946 
tested negative, giving an overall prevalence of 4.0%. 
The positive HBsAg were more likely to be found 
among the younger age groups (Table 1). 
In addition, we noted 39 HBsAg positive cases were 
found in 21 households. Among the 21 positive HBsAg 
households, 15 had only one case for each household, 
and two or more cases among six households. The 
positive HBsAg was more prevalent among households 
of five people and more. 
Positive HBsAg status was less likely to occur among 
people of high socioeconomic status compared with low 
and middle socioeconomic status; and it was more 
likely among the Chinese ethnic group. 
Positive and negative HBsAg status were similarly 
distributed with respect to gender, education, current 
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Table 1 Characteristics of subjects 
~- ~ ~ ~~ 
Hepatitis B surface antigen status Anti-hepatitis C virus status 
Positive (n = 39) Negative (n = 946) Positive (n = 38) Negative (n = 947) 
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cigarette smoking, current alcohol use and participation 
in regular sport. 
Our data showed that there were no medical risk 
factors (such as ever having jaundice, history of trans- 
fusion, history of operation, family history of jaundice, 
hepatitis B vaccination, anti-HBs, and abnormality of 
ALTlAST level) associated with HBsAg (Table 2). 
Anti HBs were found in 170 out of 985 subjects 
(17.2%). There was no significant association between 
anti-HBs and anti-HCV {OR 1.09; 95% CI 0.47-2.51). 
A suitable model to assess the probability of having 
HBsAg consisted of the variables: socioeconomic status, 
ethnic group, and family size. The relationship among 
these risk factors is shown in Table 3. 
Compared with high socioeconomic status, middle 
and low socioeconomic status (SES) were strongly asso- 
ciated with HBsAg (adjusted OR 14.72; 95% CI 
1.79-112.20 for middle SES and adjusted OR 18.09; 
95% CI 2.35-139.50 for low SES). 
The Chinese subgroup had almost a three-times 
higher risk of having HBsAg relative to the Malayan 
subgroup (adjusted OR 2.97; 95% CI 1.12-7.83). 
The trend of being HBsAg positive was moderately 
associated with the number of persons in a household 
(test for trend P<0.130). A person who lived in a 
household with five or more persons had 1.8 times the 
risk of being HBsAg positive (adjusted OR 1.84; 95% 
CI 0.82-4.12). 
Hepatitis C 
Thirty-eight subjects tested positive for anti-HCV and 
947 were negative, giving an overall prevalence of 3.9% 
(Table 1). The 38 positive anti-HCV cases were found 
in 38 households (i.e. only one case per household). 
Socioeconomic status, family size and ethnic group 
were not associated with the risk of having anti-HCV. 
Posidve and negative anti-HCV status were similarly 
distributed with respect to gender, education, current 
cigarette smoking, current alcohol use and participation 
in regular sport (Table 1). 
Other medical risk factors (such as ever having 
jaundice, history of operation, family history of jaundice, 
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Table 2 Medical risk factors related to hepatitis B surface antigen (HBsAg) and antibody to hepatitis C virus (anti-HCV) 
HBsAg status 
Positive Negative 
(n = 39) (n = 946) 
OR (95% CI) 
Anti-HCV status 
Positive Negative OR (95% CI) 
(n = 38) (n = 947) 
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1 .OO (reference) 
N/A 
0.75 (0.12-3.28) 
1 .OO (reference) 
3.87 (1.56-9.31) 
1 .OO (reference) 
1.38 (0.59-3.11) 
1 .OO (reference) 
1.88 (0.645.53) 
1.17 (0.45-3.09) 
1 .OO (reference) 
1.16 (0.35-3.88) 
1 .OO (reference) 
1.09 (0.47-2.5 1) 
1.00 (reference) 
1.42 (0.59-3.31) 
1 .OO (reference) 
1.59 (0.37-6.89) 
N/A, not available; AST, aspartate aminotransferase; ALT, a l e e  aminotransferase. 
and abnormality of ALT/AST level) were not associated 
with anti-HCV (Table 2). 
Age was identified as a strong risk factor for anti- 
HCV. Age over 50 years was strongly associated with 
anti-HCV compared with the 15-29 year age group 
(adjusted OR 14.72; 95% CI 4.35-49.89). 
Our data showed that the history of transfusion was 
strongly associated with anti-HCV (adjusted OR = 
2.95; 95% CI 1.25-7.33; Table 4). 
DISCUSSION 
There are several limitations that must be considered in 
the interpretation of our findings. We do not have data 
on tattooing, intravenous drug use, or sexual trans- 
mission. In spite of these limitations, the value of our 
observations derives largely from the use of a general 
population sample to estimate the prevalence of and 
some risk factors for HBsAg and anti-HCV in Indonesia. 
Our findings in this population-based study are 
different from the results of surveys performed pre- 
viously on blood donors. For example, a study on blood 
donors, patients with acute and chronic hepatitis, liver 
cirrhosis, hepatocellular carcinoma, and chronic 
haernodialysis that was performed in Jakarta in 1991, 
reported the prevalence of HBsAg and anti-HBs among 
blood donors to be 5.5 and 32.9%, respectively3 A 
survey of a large number of blood donors also found 
the prevalence of HBsAg among blood donors to be 
5.5%.4 These estimates of the prevalence of HBsAg 
were higher compared with our data. In the other 
islands of Indonesia such as Sumatra, Sulawesi and the 
islands of eastern Indonesia, the prevalence of HBsAg 
among blood donors was reported to be higher than our 
findings: 7.0, 12.5 and 26%, re~pectively.~ 
These differences illustrate the problems of comparing 
general population-based studies with those derived from 
selected groups of blood donors and patients. Our 
findings of lower prevalences of HBsAg and anti-HBs are 
very likely to be due to our testing a general population 
sample, whereas other studies have tested subjects known 
to be at increased risk of having HBV infection. 
Another population-based study in North Jakarta, 
where most of the respondents came from low socio- 
economic status and a younger population, found the 
prevalence of HBsAg and anti-HBs to be 3.7 and 25.6%, 
respecti~ely.'~ The exposure rates of HBV infection in that 
study (HBsAg and anti-HBs) were rather higher than in 
our study. This may be due to different demographic 
factors; for example, in the present study low socio- 
economic status is a strong risk factor for HBsAg. 
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Table 3 Relationship of socioeconomic status, ethnic 
group and family size to hepatitis B surface antigen (HBsAg) 
HBsAg status 
Positive Negative OR* (95% CI) 
(n = 39) (n = 946) 
Socioeconomic status 
High 1 237 1.00 (reference) 
Middle 17 306 14.72 (1.79-112.20) 
LOW 21 403 18.09 (2.35-139.50) 
Ethnic group 
Malay 33 870 1.00 (reference) 
Chinese 6 76 2.97 (1.12-7.83) 
Family size 
1-2 persons 11 278 1 .OO (reference) 
5 persons and over 18 293 1.84 (0.82-4.12) 
*Odds ratio for socioeconomic status adjusted for ethnic 
group and family size. Odds ratio for ethnic group adjusted 
for socioeconomic status and family size. Odds ratio for 
family size adjusted for ethnic group and socioeconomic 
status. 
3-4 persons 10 375 0.69 (0.28-1.66) 
Table 4 Relationship of age group and history of 
transfusion to antibody to hepatitis C virus (anti-HCV) 
Anti-HCV  tat^^ 
Positive Negative OR* (95% CI) 
(n = 38) (n = 947) 
Age group 
15-29 years 3 406 1 .OO (reference) 
50+ years 27 208 14.72 (4.35-49.89) 
No 30 886 1.00 (reference) 
30-49 years 8 333 2.59 (0.65-10.31) 
Transfusion history 
Yes 8 61 3.03 (1.25-7.33) 
*Odds ratio for age group adjusted for transfusion history, 
Odds ratio for transfusion history adjusted for age group. 
Our data revealed that there is a moderate positive 
trend (adjusted test for trend: P = 0.130) between 
family size and risk of HBsAg positivity. The test for 
trend was adjusted for socioeconomic and ethnic status. 
This finding was similar to those of other studies.13J6 
The Chinese population in our present study 
appeared more susceptible to acquiring the HBsAg 
carrier state. This finding is also noted in other studies 
indicating that ethnicity might play a role in the 
difference of the HBsAg prevalence and could be due to 
differences in immunological responses. 15*17 
We studied other risk factors that have been reported 
to be associated with HBsAg but none of these risk 
factors showed statistically significant associations with 
this viral infection. In contrast, history of surgery was 
reported as a risk factor for being HBsAg p~si t ive.~,~ 
This difference was most likely due to the small number 
of subjects in our study who were HBsAg positive and 
have ever had an operation (n = 6 subjects). 
A previous study in Indonesia found the prevalence 
of anti-HCV to be 2.5% among blood donors, using a 
first generation test (Ortho-HCV ELISA; Ortho 
Diagnostics, Tokyo, Japan).3 This number was in 
contrast with our finding of a prevalence of 3.9% for 
anti-HCV (using a second generation test). Our fmding 
of a higher prevalence of anti-HCV may reflect our use 
of a newer, more sensitive test rather than any true 
difference in risk of HCV or differences of respondents 
that we used. Another extensive study using a second 
generation immunosorbent assay on blood donors 
throughout Indonesia found the prevalence of anti- 
HCV among blood donors was 2.1% nationwide and 
2.5% in Jakarta. After adjustment for age, their 
estimates of anti-HCV prevalence were virtually 
identical to ours. In other islands of Indonesia such as 
Sumatra, Sulawesi and the islands of eastern Indonesia, 
the prevalence of anti-HCV among blood donors were 
lower than our findings, 1.7, 1.8 and 1.0%, respec- 
t i~ely.~ The seroprevalence in these two studies rises 
with age,3i4 similar to our findings. Studies in Japan and 
Taiwan also indicate that the seroprevalence of anti- 
HCV in blood donors and healthy individuals rises with 
age at a rate of 0.21% with each de~ade .~ . '~  
The occurrence of several risk factors for HCV 
infection vary in different geographical In 
Western countries and Australia, anti-HCV are asso- 
ciated with tattooing, intravenous drug abuse, sexual 
contact> and history of blood One study 
in Taiwan among healthy young men who did not engage 
in intravenous drug use or multiple sexual activity, 
revealed that anti-HCV was associated with tattooing, 
while in another Taiwanese study among prostitutes anti- 
HCV did not associate with tatt~oing.~*J~ The sipficant 
risk factors for anti-HCV among prostitutes were 
apparently related to a history of paid sex longer than six 
months and blood tran~fusion.'~ An extensive survey of 
7572 healthy volunteer blood donors in Indonesia 
identified age, blood transfusions and a history of surgery 
to be associated with anti-HCV, but it was not found to 
be associated with tattooing and acupun~ture.~ No intra- 
venous drug use found. 
A population-based study conducted in Jakarta in 
other urban areas found the prevalence of anti-HCV to 
be 4.4%.14 Anti-HCV was associated with age, skin 
disease, sharing toothbrush and utensils but was not 
associated with history of transfusion, tattooing, surgery, 
and intravenous drug abuse. In this study only one case 
of intravenous drug abuse The other study in 
Jakana also reported no association between anti-HCV 
cases and intravenous drug abuse.'* 
Our results indicate that increased age and history of 
transfusion, but not socioeconomic status, are strong 
risk factors for anti-HCV. We also observed other risk 
factors that might be related to anti-HCV such as 
history of surgery, alcohol use, and cigarette smoking, 
but none of these showed statistically significant 
associations with this viral infection. Our data showed 
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the familial clustering was not a risk factor for anti- 
HCV (adjusted OR 0.35; 95% CI 0.04-2.67). Further- 
more, we found only one member who had anti-HCV 
positivity for each household where there was infection. 
This finding showed that HCV infection in intra- 
familial clusters in households is low compared with 
HBV infection. 
We also noted that the Chinese population was not 
more susceptible to developing anti-HCV (Table 1). 
This finding was similar to another report in 
1ndonesia.l4. 
Our data revealed that strong risk factors for HBsAg 
differed with anti-HCV. Our findings showed the risk 
factors for HBsAg to be socioeconomic status, ethnicity, 
and family size, while the risk factors for anti-HCV 
were age group, and a history of transfusion. We found 
that poverty does not facilitate transmission of HCV, 
whereas it does facilitate HBV transmission. 
Only 2/985 (0.2%) subjects were positive for both 
HBsAg and anti-HCV, indicating that concurrent 
infection with both agents is rare. This finding is in 
close agreement with another study that found 0.18% 
of subjects in Indonesia screened were positive for 
markers of both HBV and HCV.4 Only 7/985 (0.7%) of 
our subjects were positive for both anti-HBs and anti- 
HCV and, of the 170 subjects who were positive for 
anti-HBs, seven (4.1 %) were positive for anti-HCV. 
This means the prevalence of anti-HCV in our study is 
not higher among subjects who had a recent or past 
infection with hepatitis B virus. 
In conclusion, hepatitis B and hepatitis C infections 
have different risk factors in Jakarta. Hepatitis B 
transmission is associated with low socioeconomic 
status and Chinese ethnic group, and there is a 
moderate positive trend that a large family size has 
more risk of developing hepatitis B. Hepatitis C is 
associated with older age and blood transfusions. 
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